Trial intelligence / Profile preview

SiderAL Med in Post-Stroke Fatigue

NCT05728229Recruiting

Sponsor
Policlinico Gemelli
Start
Nov 2022
Primary completion
Sep 2024
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Modified Fatigue Impact Scale at 16 weeks. Started Nov 2022; status: recruiting.

Beyond the preview

Go deeper on NCT05728229.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05728229.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call